Evidence map›Paper›PMID 33005234›Full record

ArticleEvolutionary applications2020

Controlling evolutionary dynamics to optimize microbial bioremediation.

Shota Shibasaki, Sara Mitri

Open access · goldAbstract read
In one paragraph

Article in Evolutionary applications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Parallel ecological and evolutionary responses to selection in a natural bacterial community.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Directed Evolution of Microbial Communities.Annual review of biophysics · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shota ShibasakiDepartment of Fundamental Microbiology University of Lausanne Lausanne Switzerland.ORCID https://orcid.org/0000-0002-8196-0745
Sara MitriDepartment of Fundamental Microbiology University of Lausanne Lausanne Switzerland.ORCID https://orcid.org/0000-0003-3930-5357
University of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some microbes have a fascinating ability to degrade compounds that are toxic for humans in a process called bioremediation. Although these traits help microbes survive the toxins, carrying them can be costly if the benefit of detoxification is shared by all surrounding microbes, whether they detoxify or not. Detoxification can thereby be seen as a public goods game, where nondegrading mutants can sweep through the population and collapse bioremediation. Here, we constructed an evolutionary game theoretical model to optimize bioremediation in a chemostat initially containing "cooperating" (detoxifying) microbes. We consider two types of mutants: "cheaters" that do not detoxify, and mutants that become resistant to the toxin through private mechanisms that do not benefit others. By manipulating the concentration and flow rate of a toxin into the chemostat, we identified conditions where cooperators can exclude cheaters that differ in their private resistance. However, eventually, cheaters are bound to invade. To overcome this inevitable outcome and maximize detoxification efficiency, cooperators can be periodically reinoculated into the population. Our study investigates the outcome of an evolutionary game combining both public and private goods and demonstrates how environmental parameters can be used to control evolutionary dynamics in practical applications.

Indexed as

chemostatdetoxificationeco‐evolutionary feedbackevolutionary game theorypublic goods game

Identifiers

PMID33005234
PMCPMC7513707
OpenAlexW3039111454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.